

Debug: Keywords

1. John Smith, 58M, with diabetes and coronary artery disease due for surgical intervention.

2. Surgical recommendation needed.


Debug: Prompt


1. Record: 
Patient: John Smith
Age: 58, Male
Medical History: Diabetes; multivessel coronary artery disease with left anterior descending (LAD) involvement
Vital Signs: BP 140/85 mmHg, HR 80 bpm
Laboratory Findings: Hemoglobin 9.0 g/dL
Preoperative Workup: Basic clinical assessment, coronary angiography

2. Reference: pared with angioplasty in stable coronary artery disease. Atorvastatin versus 
Revascularization Treatment Investigators. N Engl J Med. 1999;341:70–76.
 24. Chaitman BR, Hardison RM, Adler D, et al. The Bypass Angioplasty Revas-
cularization Investigation 2 Diabetes randomized trial of different treatment 
strategies in type 2 diabetes mellitus with stable ischemic heart disease: 
impact of treatment strategy on cardiac mortality and myocardial infarction. 
Circulation. 2009;120:2529–2540.
 25. Kapoor JR, Gienger AL, Ardehali R, et al. Isolated disease of the proximal 
left anterior descending artery comparing the effectiveness of percutane-
ous coronary interventions and coronary artery bypass surgery. JACC Car-
diovasc Interv. 2008;1:483–491.
 26. Jones RH, Kesler K, Phillips HR 3rd, et al. Long-term survival benefits 
of coronary artery bypass grafting and percutaneous transluminal angio-
plasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 
1996;111:1013–1025.
 27 . Aziz O, Rao C, Panesar SS, et al. Meta-analysis of minimally invasive internal 
thoracic artery bypass versus percutaneous revascularisation for isolated 
lesions of the left anterior descending artery. BMJ. 2007;334:617 .
 28. Hannan EL, Samadashvili Z, Cozzens K, et al. Comparative outcomes for 
patients who do and do not undergo percutaneous coronary intervention for 
stable coronary artery disease in New York. Circulation. 2012;125:1870–
1879.
 29. Smith PK, Califf RM, Tuttle RH, et al. Selection of surgical or percutane-
ous coronary intervention provides differential longevity benefit. Ann Thorac 
Surg. 2006;82:1420–1428. discussion 8-9.
 30. Pijls NHJ, van Schaardenburgh P, Manoharan G, et al. Percutaneous coro-
nary intervention of functionally nonsignificant stenosis: 5-year follow-up of 
the DEFER study. J Am Coll Cardiol. 2007;49:2105–2111.
 31. Hamad MAS, van Straten AHM, Schönberger JPAM, et al. Preoperative

• GE Health-
care‡
• W.L. Gore & 
Associates‡
• Centerline 
Biomedical, 
Advisory 
Board  
Member*
• Cook  
Medical†
• Philips, Advi-
sory Board 
Member
• W.L. Gore & 
Associates†
None
Laura Ogbechie Baylor College of Medicine—
Nurse Practitioner, Department 
of Cardiothoracic Surgery
None None None None None None
Susan B. Promes Penn State Health Hershey 
Medical Center—Professor and 
Chair‚ Department of Emer-
gency Medicine
None None None None None None
Elsie Gyang Ross Stanford University School of 
Medicine— Assistant Professor, 
Department of Surgery and 
Medicine
None None None None None None
Appendix 1. Continued
Committee  
Member Employment Consultant
Speakers  
Bureau
Ownership/ 
Partnership/ 
Principal
Personal  
Research
Institutional,  
Organizational, 
or Other Finan-
cial Benefit
Expert 
Witness
(Continued )
Downloaded from http://ahajournals.org by on March 14, 2025

placement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620.
 52. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for 
the management of patients with valvular heart disease: a report of the 
American College of Cardiology/American Heart Association Joint Com-
mittee on Clinical Practice Guidelines. Circulation. 2021;143:e72–e227 .
 53. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization be-
fore elective major vascular surgery. N Engl J Med. 2004;351:2795–2804.
 54. Rao NN, Coates PT. Cardiovascular disease after kidney transplant. Semin 
Nephrol. 2018;38:291–297 .
Downloaded from http://ahajournals.org by on March 13, 2025

Surgery. Reprinted from Lombardi et al.5 
Copyright 2020, with permission from 
Elsevier, Inc., the Society of Thoracic 
Surgeons, and the Society for Vascular 
Surgery.
Downloaded from http://ahajournals.org by on March 14, 2025

left main coronary artery disease in patients with diabetes. J Am Coll Cardiol. 
2019;73:1616–1628.
 12. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft 
surgery versus percutaneous coronary intervention in patients with three-
vessel disease and left main coronary disease: 5-year follow-up of the ran-
domised, clinical SYNTAX trial. Lancet. 2013;381:629–638.
 13. Stone GW, Sabik J F, Serruys PW, et al. Everolimus-eluting stents or by-
pass surgery for left main coronary artery disease. N Engl J Med. 
2016;375:2223–2235.
Downloaded from http://ahajournals.org by on March 13, 2025

tulas after cardiac surgery: incidence and late outcome during a ten-year 
follow-up. Ann Thorac Surg. 2009;88:1910–1915.
 13. Bhatti F, Dunning J. Does liberal use of bone wax increase the risk of medi-
astinitis? Interact Cardiovasc Thorac Surg. 2003;2:410–412.
 14. Kieser TM, Rose MS, Aluthman U, et al. Toward zero: deep sternal wound 
infection after 1001 consecutive coronary artery bypass procedures using 
arterial grafts: implications for diabetic patients. J Thorac Cardiovasc Surg. 
2014;148:1887–1895.
 15. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin ther-
apy versus conventional glucose management during cardiac surgery: a 
randomized trial. Ann Intern Med. 2007;146:233–243.
 16. D’Agostino RS, Jacobs J P, Badhwar V, et al. The Society of Thoracic Sur-
geons Adult Cardiac Surgery Database: 2019 update on outcomes and 
quality. Ann Thorac Surg. 2019;107:24–32.
 17 . Gelijns AC, Moskowitz AJ, Acker MA, et al. Management practices and ma-
jor infections after cardiac surgery. J Am Coll Cardiol. 2014;64:372–381.
 18. Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to prevent 
surgical site infections in acute care hospitals: 2014 update. Infect Control 
Hosp Epidemiol.  2014;35(suppl2):S66–S88.
 19. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons 
practice guideline series: blood glucose management during adult cardiac 
surgery. Ann Thorac Surg. 2009;87:663–669.
 20. Abelev Z, Seth A, Patel R, et al. Continuous insulin infusion is associated 
with a reduced post-surgical length of stay, but not with the complication 
rate, in patients with diabetes mellitus undergoing coronary artery bypass 
graft. J Endocrinol Invest. 2011;34:770–774.
 21. Ogawa S, Okawa Y, Sawada K, et al. Continuous postoperative insulin in-
fusion reduces deep sternal wound infection in patients with diabetes 
undergoing coronary artery bypass grafting using bilateral internal mam-

Lawton et al 2021 ACC/AHA/SCAI Coronary Revascularization Guideline
January 18, 2022 Circulation. 2022;145:e18–e114. DOI: 10.1161/CIR.0000000000001038e80
CLINICAL STATEMENTS 
AND GUIDELINES
the RCT of revascularization before vascular surgery did 
not report improved outcomes with PCI. 53 Nonetheless, 
because of the increased risk of cardiovascular events 
among renal transplant recipients,54 routine risk assess-
ment is often performed before consideration for trans-
plantation. When obstructive CAD is noted, many trans-
plantation surgeons are hesitant to proceed with surgery 
in this complex group of patients without revasculariza-
tion; therefore, it is common for a patient to be referred 
for revascularization in preparation for organ transplanta-
tion. In the Ischemia CKD trial, there were no differences 
in outcomes with routine revascularization even in the 
presence of severe ischemia, although only about 10% 
of enrolled patients were on the waitlist for transplanta-
tion. Even less is known about revascularization before 
liver transplantation. For this reason, it remains unclear 
whether revascularization before organ transplantation 
imparts a better outcome, and RCTs are needed to fur-
ther inform care in this complex group of patients.
ACC/AHA JOINT COMMITTEE MEMBERS
Patrick T. O’Gara, MD, MACC, FAHA, Chair; Joshua A. 
Beckman, MD, MS, FAHA, FACC, Chair-Elect; Glenn N. 
Levine, MD, FACC, FAHA, Immediate Past Chair* ; Sana 
M. Al-Khatib, MD, MHS, FACC, FAHA* ; Anastasia L. 
Armbruster, PharmD, FACC; Kim K. Birtcher, PharmD, 
MS, AACC*; Joaquin E. Cigarroa, MD, FACC*; Lisa de las 
Fuentes, MD, MS, FAHA; Anita Deswal, MD, MPH, FACC, 
FAHA; Dave L. Dixon, PharmD, FACC* ; Lee A. Fleisher, 
MD, FACC, FAHA*; Federico Gentile, MD, FACC*; Zachary 
D. Goldberger, MD, FACC, FAHA*; Bulent Gorenek, MD, 
FACC; Norrisa Haynes, MD, MPH; Adrian F. Hernandez, 
MD, MHS; Mark A. Hlatky, MD, FACC, FAHA* ; José A. 
Joglar, MD, FACC, FAHA; W. Schuyler Jones, MD, FACC;

2015;116:1358–1362.
9.6. Revascularization in Patients With SCAD
 1. Jamil A, Tajrishi FZ, Kahe F, et al. Spontaneous coronary artery dissection 
managed with a conservative or revascularization approach: a meta-analy-
sis. J Cardiovasc Med. 2020;21:42–50.
Downloaded from http://ahajournals.org by on March 13, 2025

guideline for percutaneous coronary intervention: a report of the American 
College of Cardiology Foundation/American Heart Association Task Force 
on Practice Guidelines and the Society for Cardiovascular Angiography and 
Interventions. Circulation. 2011;124:e574–e651.
 25. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for 
coronary artery bypass graft surgery: a report of the American College of 
Cardiology Foundation/American Heart Association Task Force on Practice 
Guidelines. Circulation. 2011;124:e652–e735.
Downloaded from http://ahajournals.org by on March 13, 2025

Circulation
e18 January 18, 2022 Circulation. 2022;145:e18–e114. DOI: 10.1161/CIR.0000000000001038
Circulation is available at www.ahajournals.org/journal/circ
*Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 
for detailed information. †ACC/AHA Representative. ‡ACC/AHA Joint Committee on Clinical Practice Guidelines Liaison. §ACC/AHA Task Force on Data Standards 
Representative. ‖SCAI Representative.
ACC/AHA Joint Committee on Clinical Practice Guidelines Members, see page e80.
The American Heart Association requests that this document be cited as follows: Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl 
JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, 
Sabik JF, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College 
of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e18–e114. doi: 10.1161/CIR.0000000000001038
© 2021 by the American College of Cardiology Foundation and the American Heart Association, Inc. 
ACC/AHA/SCAI CLINICAL PRACTICE GUIDELINE
2021 ACC/AHA/SCAI Guideline for Coronary 
Artery Revascularization: A Report of the 
American College of Cardiology/American Heart 
Association Joint Committee on Clinical Practice 
Guidelines
Writing Committee Members*
Jennifer S. Lawton, MD, FAHA, Chair†; Jacqueline E. Tamis-Holland, MD, FAHA, FACC, FSCAI, Vice Chair‡;  
Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI†; Eric R. Bates, MD, FACC, FAHA†; Theresa M. Beckie, PhD, FAHA†;  
James M. Bischoff, MEd†; John A. Bittl, MD, FACC†; Mauricio G. Cohen, MD, FACC, FSCAI§; J. Michael DiMaio, MD†;
3. Task: Surgical recommendation.
4. Answer:



Debug: Response

Based on the patient record and reference, a surgical recommendation for John Smith, a 58-year-old male with diabetes and multivessel coronary artery disease with left anterior descending (LAD) involvement, cannot be made without considering various factors such as the severity of the disease, overall health, and specific guidelines.

However, according to the references provided, which include guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA), the decision between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) depends on several factors, including the extent and location of the coronary artery disease, the presence of diabetes, and the patient's overall health.

For patients with multivessel disease, including those with diabetes, CABG is often recommended over PCI, especially if the disease involves the LAD. This is because CABG has been shown to have better long-term outcomes in terms of reducing the risk of death and myocardial infarction in patients with complex coronary artery disease.

Therefore, based on the information provided, CABG might be considered a suitable option for John Smith, but the final decision should be made by a healthcare professional after evaluating all relevant factors and considering the patient's individual circumstances.